Dive into a fascinating reaction as super glue meets baking soda Watch as these everyday items create an unbreakable bond and transform right before your eyes This quick trick is surprisingly powerful ...
BOSTON (AP) — BOSTON (AP) — Monte Rosa Therapeutics Inc. (GLUE) on Thursday reported a loss of $23.9 million in its third quarter. The Boston-based company said it had a loss of 29 cents per share.
Executed global exclusive development and commercialization license agreement with Novartis to advance VAV1-directed molecular glue degraders including MRT-6160 for immune-related conditions; $150M ...